busulfan has been researched along with Neoplasm Metastasis in 23 studies
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-risk neuroblastoma is characterized by poor long-term survival, especially for very high-risk (VHR) patients (poor response of metastases after induction therapy)." | 6.87 | Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience. ( Bogart, E; Chastagner, P; Cougnenc, O; Defachelles, AS; Ferry, I; Kolesnikov-Gauthier, H; Michon, J; Oudoux, A; Proust, S; Schleiermacher, G; Valteau-Couanet, D, 2018) |
| "Uveal melanoma is relatively uncommon accounting for fewer than 5% of all melanoma cases." | 6.72 | A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. ( Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA, 2006) |
| "High-risk neuroblastoma is characterized by poor long-term survival, especially for very high-risk (VHR) patients (poor response of metastases after induction therapy)." | 2.87 | Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience. ( Bogart, E; Chastagner, P; Cougnenc, O; Defachelles, AS; Ferry, I; Kolesnikov-Gauthier, H; Michon, J; Oudoux, A; Proust, S; Schleiermacher, G; Valteau-Couanet, D, 2018) |
| "Uveal melanoma is relatively uncommon accounting for fewer than 5% of all melanoma cases." | 2.72 | A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. ( Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA, 2006) |
| "It is concluded that there is no evidence that either of the two cytotoxic drugs in the dosage prescribed improved survival for the two-year period of observation, though a final evaluation of the adjuvant chemotherapy as studied in this investigation will have to await the results at five years." | 2.64 | Study of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. Report by a Medical Research Council Working Party. ( , 1971) |
| "Eighteen patients with poor risk Ewing's sarcoma (including 11 patients with metastatic disease at presentation) received consolidation therapy of busulphan and melphalan with autologous stem cell rescue." | 1.30 | High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. ( Ashley, S; Atra, A; Calvagna, V; Pinkerton, CR; Shankar, AG; Shepherd, V; Souhami, RL; Whelan, JS, 1997) |
| "The effectiveness of the treatment on metastasis was also shown by the prolongation of mean survival time in groups of mice which showed no local recurrence of tumors." | 1.27 | Therapeutic effects of PS-K and busulfan on the recurrent and metastatic diseases after the surgical removal of 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice. ( Hosokawa, M; Kobayashi, H; Mizukoshi, T; Sugawara, M, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferry, I | 1 |
| Kolesnikov-Gauthier, H | 1 |
| Oudoux, A | 1 |
| Cougnenc, O | 1 |
| Schleiermacher, G | 1 |
| Michon, J | 1 |
| Bogart, E | 1 |
| Chastagner, P | 1 |
| Proust, S | 1 |
| Valteau-Couanet, D | 2 |
| Defachelles, AS | 1 |
| Luksch, R | 1 |
| Tienghi, A | 1 |
| Hall, KS | 1 |
| Fagioli, F | 1 |
| Picci, P | 1 |
| Barbieri, E | 1 |
| Gandola, L | 1 |
| Eriksson, M | 1 |
| Ruggieri, P | 1 |
| Daolio, P | 1 |
| Lindholm, P | 1 |
| Prete, A | 1 |
| Bisogno, G | 1 |
| Tamburini, A | 1 |
| Grignani, G | 1 |
| Abate, ME | 1 |
| Podda, M | 1 |
| Smeland, S | 1 |
| Ferrari, S | 1 |
| Blaise, D | 2 |
| Bay, JO | 1 |
| Faucher, C | 1 |
| Michallet, M | 2 |
| Boiron, JM | 1 |
| Choufi, B | 1 |
| Cahn, JY | 1 |
| Gratecos, N | 1 |
| Sotto, JJ | 1 |
| François, S | 1 |
| Fleury, J | 1 |
| Mohty, M | 1 |
| Chabannon, C | 1 |
| Bilger, K | 1 |
| Gravis, G | 1 |
| Viret, F | 1 |
| Braud, AC | 1 |
| Bardou, VJ | 1 |
| Maraninchi, D | 1 |
| Viens, P | 1 |
| HARMAN, JB | 1 |
| Schmittel, A | 1 |
| Schuster, R | 1 |
| Bechrakis, NE | 1 |
| Siehl, JM | 1 |
| Foerster, MH | 1 |
| Thiel, E | 1 |
| Keilholz, U | 1 |
| Mauch, C | 1 |
| O'Neill, PA | 1 |
| Butt, M | 1 |
| Eswar, CV | 1 |
| Gillis, P | 1 |
| Marshall, E | 1 |
| Kalaycioglu, ME | 1 |
| Lichtin, AE | 1 |
| Andresen, SW | 1 |
| Tuason, L | 1 |
| Bolwell, BJ | 1 |
| Fields, KK | 1 |
| Elfenbein, GJ | 1 |
| Perkins, JB | 1 |
| Moscinski, LC | 1 |
| Atra, A | 1 |
| Whelan, JS | 1 |
| Calvagna, V | 1 |
| Shankar, AG | 1 |
| Ashley, S | 1 |
| Shepherd, V | 1 |
| Souhami, RL | 1 |
| Pinkerton, CR | 1 |
| Hartmann, O | 1 |
| Benhamou, E | 1 |
| Vassal, G | 1 |
| Rubie, H | 1 |
| Beaujean, F | 1 |
| Lemerle, J | 1 |
| Chakraborty, N | 1 |
| Bilgrami, S | 1 |
| Maness, L | 1 |
| Guo, C | 1 |
| Perez-Diez, A | 1 |
| Mukherji, B | 1 |
| Tutschka, P | 1 |
| Socié, G | 1 |
| Clift, RA | 1 |
| Devergie, A | 1 |
| Ringden, O | 1 |
| Martin, PJ | 1 |
| Remberger, M | 1 |
| Deeg, HJ | 1 |
| Ruutu, T | 1 |
| Sullivan, KM | 1 |
| Chevret, S | 1 |
| Stott, H | 2 |
| Stephens, RJ | 2 |
| Fox, W | 2 |
| Roy, DC | 1 |
| van Putten, LM | 1 |
| Kram, LK | 1 |
| van Dierendonck, HH | 1 |
| Smink, T | 1 |
| Füzy, M | 1 |
| Behr, J | 1 |
| Thyselius, D | 1 |
| Jäger, W | 1 |
| Paterok, EM | 1 |
| Girling, DJ | 1 |
| Hosokawa, M | 1 |
| Mizukoshi, T | 1 |
| Sugawara, M | 1 |
| Kobayashi, H | 1 |
| Min, KW | 1 |
| Györkey, F | 1 |
| Thornes, RD | 1 |
| Lamerton, LF | 1 |
| Visfeldt, J | 1 |
| Lundwall, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Observational Study on Treatment of Skeletal Ewing Sarcoma at Diagnosis[NCT04845893] | 100 participants (Anticipated) | Observational | 2021-06-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for busulfan and Neoplasm Metastasis
| Article | Year |
|---|---|
High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carboplatin; Cycl | 1995 |
[Primary metastasizing fallopian tube carcinoma. Case report and overview of current therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Busulfan; Cisplat | 1990 |
10 trials available for busulfan and Neoplasm Metastasis
| Article | Year |
|---|---|
Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; | 2018 |
A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cohort Studies; Deoxycytidine | 2005 |
A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Humans; | 2006 |
High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancer.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 1995 |
Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busul | 1999 |
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
Topics: Adolescent; Adult; Alopecia; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cycloph | 2001 |
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Busulfan; Clinical Trials as Topic; Cyclophosphamide; Female; Follow-Up Studies | 1976 |
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.
Topics: Aged; Busulfan; Carcinoma, Bronchogenic; Clinical Trials as Topic; Combined Modality Therapy; Cyclop | 1985 |
Oral anticoagulant therapy of human cancer.
Topics: Administration, Oral; Anticoagulants; Antineoplastic Agents; Breast Neoplasms; Busulfan; Chlorambuci | 1974 |
Study of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. Report by a Medical Research Council Working Party.
Topics: Adult; Aged; Anemia, Hemolytic; Bronchial Neoplasms; Busulfan; Clinical Trials as Topic; Cyclophosph | 1971 |
11 other studies available for busulfan and Neoplasm Metastasis
| Article | Year |
|---|---|
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2012 |
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Chronic Disease; | 2004 |
THE TREATMENT OF INCURABLE MALIGNANT DISEASE.
Topics: Adrenalectomy; Androgens; Breast Neoplasms; Busulfan; Chlorambucil; Estrogens; Heroin; Hormones; Hum | 1964 |
[Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?].
Topics: Administration, Oral; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2005 |
High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.
Topics: Adolescent; Adult; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 1997 |
Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Busulfan; Child; Child, Prescho | 1997 |
Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Busulfan; Cell Transformation, Neoplastic; Globul | 1975 |
Therapeutic effects of PS-K and busulfan on the recurrent and metastatic diseases after the surgical removal of 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice.
Topics: Adjuvants, Immunologic; Animals; Busulfan; Female; Methylcholanthrene; Mice; Mice, Inbred C57BL; Neo | 1985 |
Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Busulfan; Humans; Leukemia, Myeloid; Lung Neoplasms; Male | 1968 |
Cell proliferation and the differential response of normal and malignant tissues. Silvanus Thompson Memorial Lecture.
Topics: Animals; Blood Vessels; Busulfan; Cell Survival; Cyclophosphamide; Cytarabine; Diffusion; Epithelial | 1972 |
Alteration of karyotypic profiles in human cancerous effusion following treatment with antineoplastic drug.
Topics: Adenocarcinoma; Ascitic Fluid; Busulfan; Chromosomes; Female; Humans; Karyotyping; Lymphatic Metasta | 1970 |